A Study of IBI306 in Participants With Hypercholesterolemia

Clinical trial NCT04709536 · COMPLETED

Trial details

NCT number: NCT04709536
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypercholesterolemia

Start date: 2021-02-09
Primary completion: 2021-11-09
Enrollment: 306

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.